SAT0169 No evidence that concomitant glucocorticoid therapy affects efficacy and safety of tocilizumab monotherapy in rheumatoid arthritis clinical trials
Safy, M., Jacobs, J. W. G., Edwardes, M., Pei, J., De Hair, M., Teitsma, X., Welsing, P., Borm, M., Luder, Y., Van Laar, J., Pethö-Schramm, A., Bijlsma, J. W. J.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
FRI0026 U-act-early trial 3 years follow-up. the longer effectiveness of treat-to-target strategies in early ra with tocilizumab, methotrexate, or their combination
Verhoeven, M., de Hair, M., Welsing, P., Pethö-Schramm, A., Borm, M., Teitsma, X., van Laar, J., Lafeber, F., Bijlsma, J., Jacobs, J.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
Explorative analyses of protein biomarkers in patients with early rheumatoid arthritis achieving sustained drug-free remission after treatment with tocilizumab- or methotrexate-based strategies: from transcriptomics to proteomics
Teitsma, Xavier M, Jacobs, Johannes W G, Concepcion, Arno N, Pethö-Schramm, Attila, Borm, Michelle E A, van Laar, Jacob M, Bijlsma, Johannes W J, Lafeber, Floris P J G
Published in Clinical and experimental rheumatology (01.11.2018)
Get full text
Published in Clinical and experimental rheumatology (01.11.2018)
Journal Article
SAT0218 Effect of tocilizumab in DMARD-NAÏVE early rheumatoid arthritis patients on health-related quality of life: results of the U-ACT-EARLY trial
Teitsma, XM, Jacobs, JW, Welsing, PM, Pethö-Schramm, A, Borm, ME, Laar, JM van, Lafeber, FP, Bijlsma, JW
Published in Annals of the rheumatic diseases (01.06.2017)
Published in Annals of the rheumatic diseases (01.06.2017)
Get full text
Journal Article
OP0293 Weighted gene co-expression network analysis of DMARD-NAÏVE early ra patients achieving sustained drug-free remission after initiating tocilizumab therapy
Teitsma, XM, Jacobs, JW, Mokry, M, Pethö-Schramm, A, Borm, ME, Laar, JM van, Bijlsma, JW, Lafeber, FP
Published in Annals of the rheumatic diseases (01.06.2017)
Published in Annals of the rheumatic diseases (01.06.2017)
Get full text
Journal Article
SAT0046 Transcript-protein associations in early ra patients achieving sustained drug-free remission after treatment with tocilizumab
Teitsma, X.M., Jacobs, J.W., Concepcion, A.N., Pethö-Schramm, A., Borm, M.E., van Laar, J.M., Bijlsma, J.W., Lafeber, F.P.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
FRI0040 Development and validation of clinical predictors for inadequate response to treat-to-target methotrexate therapy in newly diagnosed ra patients
Teitsma, X.M., Jacobs, J.W., Welsing, P.M., de Jong, P.H., Hazes, J.M., Weel, A.E., Pethö-Schramm, A., Borm, M.E., van Laar, J.M., Lafeber, F.P., Bijlsma, J.W.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
FRI0203 Sustained Drug Free Remission in Early Ra Patients Treated To Target with Tocilizumab, Methotrexate or Their Combination
Teitsma, X.M., Jacobs, J.W., Welsing, P.M., Woodworth, T.G., Pethö-Schramm, A., Borm, M.E., Bernasconi, C., Lafeber, F.P., Bijlsma, J.W.
Published in Annals of the rheumatic diseases (01.06.2016)
Published in Annals of the rheumatic diseases (01.06.2016)
Get full text
Journal Article
FRI0040 Protein Biomarkers Improves The Prediction of Clinical Response To Methotrexate Step-Up Strategy in Early RA Patients
Teitsma, X.M., Jacobs, J.W., Welsing, P.M., Woodworth, T.G., Pethö-Schramm, A., Borm, M.E., Bernasconi, C., van Laar, J.M., Bijlsma, J.W., Lafeber, F.P.
Published in Annals of the rheumatic diseases (01.06.2016)
Published in Annals of the rheumatic diseases (01.06.2016)
Get full text
Journal Article